Pharmx Technologies Limited (ASX:PHX)

Pharmx Technologies Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	2.57	4.17	13.14	12.81	5.76
Cash & Short-Term Investments	2.57	4.17	13.14	12.81	5.76
Cash Growth	-38.38%	-68.24%	2.58%	122.36%	-11.10%
Accounts Receivable	1.01	0.98	0.98	0.91	1.03
Other Receivables	1.79	0.51	2.18	1.7	1.61
Receivables	2.8	1.49	3.15	2.61	2.63
Inventory	-	-	-	-	0.04
Prepaid Expenses	0.11	0.1	-	-	-
Other Current Assets	2.02	-	0.08	7.18	0.15
Total Current Assets	7.5	5.76	16.37	22.59	8.59
Property, Plant & Equipment	0.55	0.81	0.24	0.05	0.6
Goodwill	2.12	2.12	2.12	2.12	2.12
Other Intangible Assets	9.64	9.68	10.82	11.24	18.61
Long-Term Deferred Tax Assets	0.18	0.17	0.22	0.53	0.71
Other Long-Term Assets	7.28	0.31	0.09	-	0.15
Total Assets	27.27	18.83	29.86	36.52	30.77

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	1.41	0.52	0.57	0.67	0.84
Accrued Expenses	0.18	0.14	0.15	0.13	0.88
Current Portion of Leases	0.28	0.35	0.11	0.03	0.3
Current Unearned Revenue	-	0.03	0.01	9.46	1.4
Other Current Liabilities	1.35	0.7	11.12	2	1.69
Total Current Liabilities	3.22	1.73	11.95	12.29	5.11
Long-Term Leases	0.27	0.54	0.13	-	0.02
Pension & Post-Retirement Benefits	0.04	0.06	0.04	0.02	0.1
Long-Term Deferred Tax Liabilities	0.46	0.56	0.87	1.01	1.02
Other Long-Term Liabilities	0.01	0.01	0.89	0.99	1.31
Total Liabilities	3.99	2.9	13.89	14.31	7.57

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	102.67	93.97	93.97	98.41	98.37
Retained Earnings	-80.11	-78.29	-78.02	-76.25	-75.2
Comprehensive Income & Other	0.73	0.24	0.02	0.06	0.04
Shareholders' Equity	23.28	15.93	15.97	22.21	23.2
Total Liabilities & Equity	27.27	18.83	29.86	36.52	30.77

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	0.54	0.89	0.24	0.03	0.33
Net Cash (Debt)	2.03	3.28	12.9	12.77	5.43
Net Cash Growth	-38.04%	-74.58%	0.95%	135.12%	-11.76%
Net Cash Per Share	0.00	0.01	0.02	0.02	0.01
Filing Date Shares Outstanding	666.12	598.51	598.51	597.38	596.76
Total Common Shares Outstanding	659.46	598.51	598.51	597.38	596.76
Working Capital	4.28	4.03	4.42	10.3	3.47
Book Value Per Share	0.04	0.03	0.03	0.04	0.04
Tangible Book Value	11.53	4.14	3.04	8.85	2.48
Tangible Book Value Per Share	0.02	0.01	0.01	0.01	0.00
Machinery	-	-	-	0.18	2.52
Leasehold Improvements	-	-	-	0.09	0.09

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 9, 2026

Data Sources Report a data error